Mr. Qiang Ge joined Chengdu New Radiomedicine Technology Co., Ltd. in 2016 and currently serves as Head of Generic Drug R&D.

He holds a B.S. and M.S. from Chengdu University of Traditional Chinese Medicine. Prior to joining the company, Mr. Ge held R&D management positions at organizations including Di’ao, where he led the development of four Class one innovative chemical drugs and four generic drugs. Among these, two Class 1one new drugs were approved by the National Medical Products Administration (NMPA) to enter clinical trials.